Literature DB >> 20569600

Efficacy of 3-D Reconstructed Time of Flight MRA Follow-up of the Embolized Cerebral Aneurysms.

T Saguchi1, Y Murayama, T Ishibashi, M Ebara, K Irie, H Takao, T Abe.   

Abstract

SUMMARY: A follow-up of the embolized cerebral aneurysm with Guglielmi Detachable Coils (GDC) were performed mainly using craniograms and digital subtraction angiograms (DSA) so far.Recently, several authors have reported about efficacy of the time of flight (TOF) magnetic resonance angiogram (MRA) as a follow-up for the embolized cerebral aneurysms. In our institution, 3-D reconstructed TOF MRAs have been performed as a follow-up of the embolized cerebral aneurysms.We examined efficacy of 3-D reconstructed TOF MRA. 3-D TOF MRA was performed for a followup of the embolized cerebral aneurysms at our outpatient clinic in 35 patients. Morphological examination of the 3-D images between 3-D TOF MRA and 3-D DSA was performed. Almost similar images of 3-D MRA were obtained after 3-D reconstruction as compared with those of 3-D DSA. In three cases, recanalization was suspected in the 3-D TOF MRA. And recanalization was confirmed in the 3-D DSA actually. A quality of 3-D TOF MRA for a diagnosis of recanalization was good and practical. However, in two cases, arteries were partially disappeared in the 3-D TOF MRA.These were the artifact due to coil mass and this is a current limitation of 3-D TOF MRA. The images of 3-D TOF MRA that were reconstructed in the 3-D workstation were very similar to those of 3-D DSA. 3-D reconstructed TOF MRA was very useful for a less-invasive diagnosis of a recanalization of the embolized cerebral aneurysms.

Entities:  

Year:  2006        PMID: 20569600      PMCID: PMC3387966          DOI: 10.1177/15910199060120S104

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  4 in total

1.  Prospective evaluation of time-of-flight MR angiography in the follow-up of intracranial saccular aneurysms treated with Guglielmi detachable coils.

Authors:  L Brunereau; J P Cottier; C B Sonier; B Medioni; P Bertrand; P Rouleau; D Sirinelli; D Herbreteau
Journal:  J Comput Assist Tomogr       Date:  1999 Mar-Apr       Impact factor: 1.826

2.  Diagnostic accuracy of magnetic resonance angiography for cerebral aneurysms in correlation with 3D-digital subtraction angiographic images: a study of 133 aneurysms.

Authors:  Mika Okahara; Hiro Kiyosue; Masanori Yamashita; Hirohumi Nagatomi; Hiroyuki Hata; Toshiyuki Saginoya; Yoshiko Sagara; Hiromu Mori
Journal:  Stroke       Date:  2002-07       Impact factor: 7.914

3.  Three-dimensional time-of-flight MR angiography for evaluation of intracranial aneurysms after endosaccular packing with Guglielmi detachable coils: comparison with 3D digital subtraction angiography.

Authors:  Mika Okahara; Hiro Kiyosue; Yuzo Hori; Masanori Yamashita; Hirofumi Nagatomi; Hiromu Mori
Journal:  Eur Radiol       Date:  2004-04-21       Impact factor: 5.315

4.  Time-of-flight MR angiography targeted to coiled intracranial aneurysms is more sensitive to residual flow than is digital subtraction angiography.

Authors:  Naoaki Yamada; Katsuhiko Hayashi; Kenichi Murao; Masahiro Higashi; Koji Iihara
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

  4 in total
  3 in total

1.  Role of neuroradiology in evaluating cerebral aneurysms.

Authors:  A Stafa; M Leonardi
Journal:  Interv Neuroradiol       Date:  2008-10-09       Impact factor: 1.610

Review 2.  MR angiography in the follow-up of intracranial aneurysms treated with Guglielmi detachable coils: systematic review and meta-analysis.

Authors:  Thomas C Kwee; Robert M Kwee
Journal:  Neuroradiology       Date:  2007-07-24       Impact factor: 2.804

Review 3.  MRA versus DSA for follow-up of coiled intracranial aneurysms: a meta-analysis.

Authors:  M J van Amerongen; H D Boogaarts; J de Vries; A L M Verbeek; F J A Meijer; M Prokop; R H M A Bartels
Journal:  AJNR Am J Neuroradiol       Date:  2013-09-05       Impact factor: 3.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.